The purpose of our study was to determine whether ethyl pyruvate could inhibit the expression and release of both early (TNF-α, IL-2, IL-6, IL-1β) and late (HMGB1 ) cytokines in Con A-induced autoimmune hepatitis. Here, IL2 is linked to autoimmune hepatitis.